Deal Watch

Deal Watch: Lilly Turns To Oblique For Antibody Discovery

 
• By Joseph Haas

Plus deals involving Lilly/Oblique, Rafael Holdings/Cyclo, ADCendo/Multitude, Ocuvex/Visiox and more.

Deal Watch: Revance To Go Private In Crown Laboratories Buyout

 
• By Joseph Haas and Vibha Ravi

Plus deals involving AstraZeneca/Conduit, Recursion/Exscientia, G1/Pharmacosmos, Sanofi/Vir, Passage Bio/GEMMA and Lupin/Evofem. Also including deals in brief.

Asia Deal Watch: Ocumension Obtains Chinese Rights To Eight Alcon Products

 
• By Joseph Haas, Dexter Jie Yan, Vibha Ravi, and Anju Ghangurde

Also deals involving WuXi/Medigene, Eisai/Seed, Genor/Two River/Third Rock Ventures, ImmuneOnco/Instil, Biocytogen/Ideaya, Takeda/Dr Reddy’s/Zydus/Mankind and deals in brief.

Deal Watch: BI Acquires Nerio For Novel Immune Checkpoint Inhibitor

 
• By Joseph Haas and Mary Jo Laffler

Featuring deals involving Novartis/Dren, Palvella/Pieris, Eyenovia/Senju, Addex/Johnson & Johnson, Agilent/BioVectra, Meitheal/Nabriva, plus tech transfer agreements and deals in brief.

Asia Deal Watch: Orum, Vertex Team Up On Gene Editing Conditioning Agents

 
• By Joseph Haas, Dexter Jie Yan, Lisa Takagi, and Jung Won Shin

Plus deals involving Eisai/Sato, Keymed/Belenos, Taiho/Arcus, IASO/Innovent, Biocytogen/SOTIO, Ensol/Spine, TMS/Hokkaido University and Yuhan/Ubix.

Deal Watch: AbbVie Offloads Three Cystic Fibrosis Candidates To Sionna

 
• By Joseph Haas

Plus deals involving Abeona/Beacon, TuHura/Kintara, Crosswalk/Codexis, Lantheus/Life Molecular Imaging as well as tech transfer agreements and small deals involving Pfizer, Sanofi and Ipsen.

Asia Deal Watch: ProGen To Partner With Rani On GLP-2 Agonist In Obesity

 
• By Joseph Haas, Jung Won Shin, and Lisa Takagi

Plus deals involving Healios/Astellas Institute for Regenerative Medicine, Otsuka/Ionis, IMBiologics/Navigator and more.

Deal Watch: Lilly Partners With OpenAI On Drug-Resistant Pathogens

 
• By Joseph Haas

Plus transactions involving ANI/Alimera, Gilead/ashibio, Sanofi/Belharra and more.

Asia Deal Watch: Chugai Extends Relationship With Helsinn

 
• By Joseph Haas, Vibha Ravi, Dexter Jie Yan, Lisa Takagi, and Jung Won Shin

Plus deals involving Kissei/JWP, Shionogi/Cilcare, Takeda/Torrent, Genome & Co./Debiopharm, Kaken/J&J, CStone/Ewopharma, MediLink/BioNTech and more.

Deal Watch: Vanda Gets Competing Offer From Cycle After Unsolicited Future Pak Bid

 
• By Joseph Haas

Plus deals involving GSK/Elsie, Lilly/QurAlis, Gilead/Cartography as well as tech transfer announcements and deals in brief.

Deal Watch: Merck KGaA Enhances Cell/Gene Therapy Capabilities With Mirus Takeout

 
• By Joseph Haas, Vibha Ravi, and Dexter Jie Yan

Plus deals involving Immunis/Toray, AstraZeneca/Nona, Swixx/Biopas, Deimos/G1, Serum Institute of India/IntegriMedical/ImmunityBio plus tech transfer agreements and deals in brief.

Deal Watch: AbbVie Pursues Novel Neuropsychiatric Drug Class With Gilgamesh

 
• By Joseph Haas, Vibha Ravi, and Lisa Takagi

Plus transactions involving Sanofi/Fulcrum, Reneo/OnKure, Lilly/Mitsubishi Tanabe, Lantern/Oregon, Zydus/Eiger and more.

Asia Deal Watch: Ono Calls On PRISM BioLab’s Capabilities

 
• By Lisa Takagi, Jung Won Shin, Dexter Jie Yan, and Joseph Haas

Plus transactions involving Nissan Chemical/Sanwa Kagaku, Memel/Therabest, Chugai/Alnylam, Takeda/Kumquat, Nxera/Handok, 3SBio/CStone and deals in brief.

Deal Watch: Bristol Adds To Vaccines ‘Repertoire,’ Takes ‘Scenic’ View Of Cellular Pathways

 
• By Joseph Haas

BMS partners with Repertoire and Scenic, plus deals involving: G1/Pepper, Harmony/Epygenix, Biodexa/Emtora, Regeneron/Mammoth, Vertex/Treefrog and Immedica/KKR/Impilo.

Deal Watch: Six Small Biopharma Mergers Reflect Recent Trend

 
• By Joseph Haas

M&A edition: Mergers by Century/Clade, Eliem/Tenet, Kintara/TuHURA, Aditxt/Appili, Onconova/Traws and Apotex/Searchlight follow other companies joining forces in a tight cash environment.

Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables

 
• By Joseph Haas

Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.

Sponsored content story

 
• By Olga Zviezdicheva

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Praesent venenatis quis felis semper hendrerit. Sed mattis libero ac dictum varius. Aliquam erat volutpat. Morbi scelerisque dolor neque, ut tristique tellus malesuada quis. Cras rhoncus velit sed nisi finibus pellentesque. Aliquam euismod, neque et dictum lacinia, elit ex consectetur.

Asia Deal Watch: Nippon Shinyaku Takes On Intractable Rare Disease With MiNA

 
• By Joseph Haas, Dexter Jie Yan, Vibha Ravi, Lisa Takagi, and Anju Ghangurde

Plus deals involving Incyte/CMS, Biocytogen/ABL, Bharat/Biofabri/Bilthoven, Dr. Reddy’s/Pharmazz, Veeda/Heads, Sosei Heptares/GSK, BioGeometry/Sanyou, Ono/Sibylla and Teijin/BioProjet

Deal Watch: Gilead Acquires Xilio’s IL-12 Activating Candidate

 
• By Joseph Haas and Alaric DeArment

Plus deals involving Avalo/AlmataBio, AbbVie/Parvus, NovaBay/Eyenovia, Bayer/Aignostics, Merck & Co./Pearl, tech transfer agreements and deals in brief.

Deal Watch: Biogen, AbCellera Team To Find Novel Way To Cross Blood-Brain Barrier

 
• By Joseph Haas and Lisa Takagi

Plus deals involving BiomX/Adapative Phage, One/NEX-I, Shionogi/FunPep, Taiho/Haihe, Kinnate/Pierre Fabre, StemCell Technologies/SQZ and more, as well as tech transfer agreements.

ADVERTISEMENT